Status:
NOT_YET_RECRUITING
HIV Self-Testing and Long-Acting Injectables for HIV Treatment and Prevention Among Commercial Minibus Drivers (I-TEST LAIs) in Nigeria
Lead Sponsor:
George Washington University
Collaborating Sponsors:
The George Washington University Milken Institute School of Public Health (GWU)
Conditions:
HIV
Eligibility:
MALE
18+ years
Phase:
PHASE4
Brief Summary
Long-acting injectable antiretroviral therapy (LAI ART) and Pre-Exposure Prophylaxis (LAI PrEP) have the potential to transform HIV treatment and prevention, especially in reaching individuals such as...
Detailed Description
Commercial minibus drivers constitute a large social network of highly mobile men who work long and demanding hours, are at increased risk for HIV, and have limited time to seek health services for HI...
Eligibility Criteria
Inclusion
- Male commercial minibus drivers who have worked as a driver for at least 6 months
- 18 years old or older
- Currently and planning on residing in one of the LGAs during the next 12 months
- Owning a mobile phone
Exclusion
- Known HIV positivity
- Not ability to provide informed consent3
- No access to a cell phone
Key Trial Info
Start Date :
February 1 2026
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
August 1 2029
Estimated Enrollment :
400 Patients enrolled
Trial Details
Trial ID
NCT07000513
Start Date
February 1 2026
End Date
August 1 2029
Last Update
July 1 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
National Institute of Medical Research
Lagos, Lagos, Nigeria